We are live on
!
Find out more
ABLA
Alan B. Lancz & Associates Portfolio holdings
AUM
$103M
1-Year Est. Return
31.99%
This Fund
S&P 500
This Quarter
Est. Return
-13.6%
1 Year Est. Return
+31.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$12.1M
(-11%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
31.96%
Holding
194
New
45
Increased
6
Reduced
103
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$61.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$51.6M |
| 3 |
Allison Transmission
ALSN
|
+$650K |
| 4 |
MP Materials
MP
|
+$545K |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
+$375K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.04M |
| 2 |
GSK
GSK
|
+$646K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$413K |
| 4 |
Microsoft
MSFT
|
+$285K |
| 5 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$267K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Healthcare | 13.6% |
| 3 | Communication Services | 12.1% |
| 4 | Financials | 9.86% |
| 5 | Consumer Staples | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
VF Corp
VFC
$5.89B
| $130K | 0.13% |
+2,900
| New | +$145K |
|
177
Corning
GLW
$143B
| $129K | 0.13% |
+3,506
| New | +$121K |
|
178
STAAR Surgical
STAA
$1.21B
| $129K | 0.13% |
+1,600
| New | +$103K |
|
179
Boeing
BA
$185B
| $127K | 0.13% |
800
-400
| -33% | -$59K |
|
180
Visa
V
$677B
| $127K | 0.13% |
+600
| New | +$124K |
|
181
Carpenter Technology
CRS
$28.4B
| $125K | 0.12% |
+3,900
| New | +$139K |
|
182
Freeport-McMoran
FCX
$97.5B
| $125K | 0.12% |
+3,950
| New | +$158K |
|
|
HBI
183
DELISTED
Hanesbrands
HBI
| $125K | 0.12% |
11,147
-1,300
| -10% | -$16.2K |
|
184
Moody's
MCO
$82.7B
| $124K | 0.12% |
+400
| New | +$120K |
|
185
Ericsson
ERIC
$33.3B
| – | – |
-13,000
| Closed | -$119K |
|
186
Ford
F
$55.7B
| – | – |
-9,057
| Closed | -$153K |
|
187
Fresenius Medical Care
FMS
$12.9B
| – | – |
-6,050
| Closed | -$204K |
|
|
188
GSK
GSK
$106B
| – | – |
-11,860
| Closed | -$646K |
|
|
SFB
189
Stifel Financial Corp 5.20% Senior Notes due 2047
SFB
| – | – |
-8,650
| Closed | -$215K |
|
|
PSTH
190
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| – | – |
-12,531
| Closed | -$249K |
|
|
PBCT
191
DELISTED
People's United Financial Inc
PBCT
| – | – |
-10,300
| Closed | -$206K |
|
|
SI
192
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| – | – |
-3,860
| Closed | -$267K |
|
|
PC
193
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| – | – |
-20,566
| Closed | -$199K |
|
Similar funds
GWL
RC
EFT
SAM
CC
SPCM
DI
OPAM
Alan B. Lancz & Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Alan B. Lancz & Associates held 194 positions worth $101M, down 11% from $113M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Alan B. Lancz & Associates deployed $111M of net new capital in Q2 2022, opening 45 new positions and adding to 6 existing holdings. Its largest new stake was MP Materials: 13,500 shares worth $453K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Apple, an estimated $1.04M trimmed.
- Alan B. Lancz & Associates's largest Q2 2022 buy was MP Materials: 13,500 shares worth $453K.
- Alan B. Lancz & Associates added most to Alphabet (Google) Class A in Q2 2022, an estimated $61.2M increase.
- Alan B. Lancz & Associates's biggest Q2 2022 reduction was Apple, cutting an estimated $1.04M.
- Alan B. Lancz & Associates fully exited GSK in Q2 2022, selling an estimated $646K.
- Alan B. Lancz & Associates's ten largest holdings make up 32% of its $101M portfolio in Q2 2022.
- Alan B. Lancz & Associates opened 45 new positions and closed 10 in Q2 2022.
- Alan B. Lancz & Associates's portfolio value fell 11% quarter-over-quarter to $101M.
Based on Alan B. Lancz & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.